Childhood Cancer: Research Challenge & Future of Therapy

MARCH 3rd - MARCH 6th

DAY ONE:
SUNDAY, MARCH 3rd 2019

Opening Remarks/Reception

7:00pm - 9:00pm

Dr. Peter Houghton

Director, Greehey Children's Cancer Research Institute - UT Health San Antonio

 

DAY TWO:
MONDAY, MARCH 4th 2019

SESSION ONE: Genomics

8:30am - 1:30pm

 

Breakfast

7:30am - 8:30am

 

Keynote Speaker


8:30am - 9:15am

 


Brigitte C. Widemann, MD

Chief, Pediatric Oncology Branch, NIH/NCI Head, Pharmacology and Experimental Therapeutics Section - Senior Investigator, CCR Deputy Director,
NCI - Center for Cancer Research

 

She is a senior investigator and head of the Pharmacology and Experimental Therapeutics Section (PETS). After obtaining her M.D., from the University of Cologne (Cologne, Germany) in 1986, Dr. Widemann received board certification in pediatrics in 1992 and was a hematology/oncology fellow at NCI Pediatric Oncology Branch from 1992 to 1995. She subsequently joined the PET Section and received tenure at NCI in 2009. Her primary research interests are in the development of early clinical trials for children and young adults with refractory cancers and genetic tumor predisposition syndromes such as neurofibromatosis type 1 (NF1), and multiple endocrine neoplasia types 2A (MEN2A) and 2B (MEN2B).

Dr. Widemann and her colleagues have developed novel imaging methods for NF1-related plexiform neurofibromas and pioneered the development of early phase drug treatments for this patient population. Dr. Widemann leads multiple clinical trials of new investigational agents in pediatric refractory cancers and NF1. She also serves as the NCI Pediatric Oncology Branch principal investigator of the Children’s Oncology Group Phase I Consortium and of the Department of Defense-sponsored Neurofibromatosis Consortium.

David Malkin, MD, FRCP(C), FAAP

9:15am - 10:00am

Director, Cancer Genetics Program -
The Hospital for Sick Children in Toronto

Charles G. Mullighan, MBBS (Hons), MSC, MD

10:00am - 10:40am

Co-Leader, Hematological Malignancies Program - St. Judes Children's Research Hospital

Break

10:40am - 11:00am

Marc Remke, MD, PhD

11:00am - 11:40am

Co-Leader, Pediatric Neuro-Oncogenomics - University of Dusseldorf

Paul S. Meltzer, MD, PhD

11:40am - 12:00pm

Senior Investigator, Genetics Branch -
NCI/CCR

Lunch

12:00- 1:00pm

Short Talk, 1

1:00pm - 1:15pm

Short Talk, 2

1:15pm - 1:30pm

SESSION TWO: Epigenetics & Pathways in Pediatric Cancer

1:30am - 4:30pm

 

Charles W.M. Roberts, MD, PhD

1:30pm - 2:10pm

Director, Comprehensive Cancer Center
Director, Molecular Oncology Division -
St. Judes Children's Research Hospital

Eleanor Chen, MD, PhD

2:10pm - 2:50pm

Assistant Professor, Department of Pathology, University of Washington

Kimberly Stegmaier, MD

2:50am - 3:30pm

Associate Professor,Pediatrics, Harvard Medical School

Break

3:30pm - 3:50pm

Steven L. Lessnick , MD, PhD

3:50am - 4:30pm

Director - Center for Childhood Cancer and Blood Diseases, Nationwide Children's

SESSION THREE: Poster Session

4:30pm - 7:00pm

 

DAY THREE:
TUESDAY, MARCH 5th 2019

SESSION FOUR: Immunotherapy

8:30am - 12:00pm

 

Breakfast

7:30am - 8:30pm

 

Paul Sondel, MD, PhD

8:30am - 9:10am

Professor, Pediatric Oncology, Univeristy of Wisconsin-Madison

Terry Fry, MD

9:10am - 9:50am

Co-Director of the Human Immunology & Immunotherapy Initiative,
University of Colorado School of Medicine

Crystal Mackall, MD

9:50am - 10:30am

Professor of Pediatrics, Stanford

Michael C V Jenson, MD

10:50am - 11:30am

Professor, Ben Towne Center for Childhood Cancer Research, Seattle Children's

Short Talk, 3

11:30pm - 11:45pm

`

Short Talk, 4

11:45pm - 12:00pm

Lunch

12:00 - 1:00pm

SESSION FIVE: Advocate & Outcomes (Roundtable Style)

1:00 - 2:40pm

Greg Aune, MD, PhD

1:00pm - 2:40pm

Assistnat Professor, Greehey Children's Cancer Research Institute

Susan Weiner, PhD

1:00pm - 2:40pm

Founder, Children's Cause Cancer Advocacy

Kevin Oeffinger, MD

1:00pm - 2:40pm

DCI Supportive Care and Survivorship Center, Duke Cancer Institute

Saro Armenian, DO, MPH

1:00pm - 2:40pm

Director of the Childhood Cancer Survivorship Clinic, City of Hope

SESSION SIX: Poster Session

2:40pm - 4:00pm

 

DAY FOUR:
WEDNESDAY, MARCH 6th 2019

SESSION SEVEN: Theraphy & Drug Discovery

7:30am - 12:10pm

 

Breakfast

7:30am - 8:30am

 

Louis F. Stancato, PhD

9:00am - 10:00am

Research Fellow, Eli Lily

Craig M. Crews, PhD

10:00am - 10:40am

Professor of Molecular, Cellular, and Developmental Biology,
Professor of Chemistry Professor of Pharmacology,
Yale

Cigall Kadoch, PhD

11:00am - 11:40am

Assistant Professor of Pediatric Oncology, Dana-Farber Cancer Institute

Short Talk 5

11:40am - 11:55am

Short Talk 6

11:40am - 11:55am